thalidomide has been researched along with phenylephrine hydrochloride in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Jörgensen, G | 1 |
Bagot, M; Benchikhi, H; Bodemer, C; de Prost, Y; Delfau-Larue, MH; Fraitag, S; Gounod, N; Revuz, J; Wechsler, J | 1 |
Goyonlo, VM; Taghavi, F; Vahabi-Amlashi, S | 1 |
Akay, BN; Cengiz Seval, G; Erol, HM; Kalay Yildizhan, I; Kırmızı, A; Kuzu, I; Sanli, H | 1 |
5 other study(ies) available for thalidomide and phenylephrine hydrochloride
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
[Malformations in otorhinolaryngology. Genetic report].
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Child; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, 16-18; Congenital Abnormalities; Deafness; Down Syndrome; Ear; Ear, External; Hepatitis; Humans; Larynx; Male; Mutation; Nose; Thalidomide; Trisomy | 1972 |
Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases.
Topics: Adolescent; Adult; B-Lymphocytes; Dermatologic Agents; Facial Dermatoses; Female; Humans; Male; Nose; Pseudolymphoma; Thalidomide | 1999 |
Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Humans; Iran; Leishmania tropica; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Nose; Thalidomide; Young Adult | 2019 |
Rosai-Dorfman disease presenting with nasal, nodal and multiple cutaneous involvements responding to a combination of systemic steroid and low-dose thalidomide therapy.
Topics: Histiocytosis, Sinus; Humans; Nose; Skin Diseases; Steroids; Thalidomide | 2021 |